Medical weight loss with the much-talked-about Mounjaro injection

  • Published:
  • Updated:
  • Written by the Hiro Clinic Medical Weight Loss editorial team
  • 43 min read
Medically reviewed by Dr. Hiroko Oka Reviewed byDr. Hiroko OkaCertified Member, Japanese Society of Internal Medicine Editorial policy
Medical weight loss with the much-talked-about Mounjaro injection

Mounjaro injections act on two hormones, GLP-1 and GIP, at the same time, making Mounjaro one of the most closely watched medical weight-loss drugs today. In recent years, Mounjaro (Mounjaro®; generic name: tirzepatide) has attracted worldwide attention as a “weight-loss injection.” It was originally developed as a treatment for diabetes, but because of its strong weight-loss effect it has also been approved as an anti-obesity drug in the US and Europe, and a large body of clinical data has been accumulated.
In Japan, it is still approved only as a diabetes treatment, but it is increasingly being used for medical weight loss as self-pay treatment. In this article, we explain in specialist detail how Mounjaro works, its clinical data, how it is actually used, its side effects and precautions, and the differences between the situation in Japan and overseas.

The short answerIf you are busy, just read this

  • Mounjaro was introduced in 2022 as the world’s first dual receptor agonist, acting on two receptors: GLP-1 and GIP
  • Mounjaro helps with weight loss because several effects work at the same time: suppressing appetite, prolonging fullness, stabilizing blood sugar and improving metabolism
  • Mounjaro has a strong weight-loss effect, but it is essential to understand side-effect management and the fact that it is self-pay treatment

What you will learn in this article

  • How Mounjaro, as a dual GLP-1/GIP receptor agonist, produces its weight-loss effect
  • Specific weight-loss figures from the SURMOUNT-1 and SURPASS trials
  • The once-weekly dosing schedule and tips for reducing side effects
  • Why the approved uses differ between Japan and other countries, and why it is self-pay treatment
  • Precautions you should be sure to understand when considering starting treatment

1. What is Mounjaro? Background and features

Mounjaro was introduced in 2022 as the world’s first dual receptor agonist, acting on two receptors: GLP-1 and GIP. Mounjaro (Mounjaro®; generic name: tirzepatide) is a new injectable drug approved by the US FDA (Food and Drug Administration) in 2022 as a treatment for type 2 diabetes. What sets it apart from earlier diabetes drugs and weight-loss injections is that it harnesses the actions of two hormones, GLP-1 and GIP, at the same time. For this reason, it is called a “dual receptor agonist.”

The GLP-1 drugs that had been mainstream until now (such as Ozempic and Rybelsus) mainly worked by suppressing appetite and slowing the stomach to prolong fullness. Mounjaro, on the other hand, uses the action of GIP in addition to GLP-1, which allows it to improve metabolism as a whole more strongly.

  • GLP-1 (glucagon-like peptide-1)
    It suppresses appetite, slows the emptying of stomach contents to keep you feeling full longer, and stimulates insulin secretion to lower blood sugar.
  • GIP (gastric inhibitory polypeptide)
    In addition to further increasing insulin secretion, it promotes the uptake of glucose into fat and muscle and makes energy metabolism more efficient.

The greatest feature of Mounjaro is that this “dual GLP-1 + GIP action” makes it possible to achieve blood sugar control and weight loss at the same time. In other words, it offers benefits not available with earlier drugs: easier blood sugar management for patients with diabetes, and expected weight loss for people prone to obesity.

In addition, overseas its use as an “anti-obesity drug” is spreading regardless of whether people have diabetes, and clinical data have confirmed a strong weight-loss effect. As a result, it has become one of the most closely watched medical weight-loss drugs in the world.

2. Effects for medical weight loss — what the clinical data show

Mounjaro’s weight-loss effect is supported by two large clinical trials: SURMOUNT-1 and SURPASS. The effect of Mounjaro has already been demonstrated in several large clinical trials. Here we present the results of the representative “SURMOUNT” and “SURPASS” trials.

2-1. SURMOUNT-1 trial (patients with obesity)
The “SURMOUNT-1 trial” was conducted in patients with obesity who did not have diabetes. Participants had a BMI of 30 or higher, or a BMI of 27 or higher with an obesity-related condition, and received the drug for 72 weeks.

The results showed that the higher the dose, the greater the weight-loss effect, with the following outcomes reported.

  • 5 mg group → average weight loss of about 15%
  • 10 mg group → average loss of about 19.5%
  • 15 mg group → average loss of about 20.9%

In other words, the highest-dose group achieved an effect strong enough to reduce body weight by one-fifth. As secondary effects, reductions in lifestyle-disease risk were also confirmed, such as improved blood pressure, lower triglycerides and higher “good” cholesterol (HDL).

2-2. Weight loss in patients with diabetes (SURPASS trials)
The “SURPASS trials” in patients with type 2 diabetes also clearly showed a weight-loss effect. In patients with diabetes, insulin resistance is often strong due to obesity, making weight control difficult in many cases, but treatment with Mounjaro resulted in an average weight loss of 8–12%.

In addition, a reduction in HbA1c, an indicator of blood sugar control, and improved insulin sensitivity were also seen, so it is highly regarded not only for weight loss but also for its usefulness as a diabetes treatment.

In this way, Mounjaro is not just a “weight-loss injection” but can be described as a drug with multifaceted effects that reduce the risk of complications associated with obesity disease and diabetes.

3. Why does it cause weight loss? How it works in detail

Mounjaro helps with weight loss because several effects work at the same time: suppressing appetite, prolonging fullness, stabilizing blood sugar and improving metabolism. Mounjaro is called a “weight-loss injection” not simply because it reduces appetite. By acting on several of the body’s mechanisms at once, it achieves efficient and sustained weight loss.

First, it acts on the hypothalamus, the part of the brain that controls appetite, to suppress hunger. This naturally reduces “overeating without meaning to,” helping you eat less without forcing yourself to hold back.

Next, it has the effect of slowing stomach emptying. Because it slows the rate at which food moves from the stomach to the intestines, you stay full for longer even after a small meal, which prevents “getting hungry again right away.”

Mounjaro also has the effect of stabilizing blood sugar. By curbing post-meal blood sugar spikes (sharp rises in blood sugar), it helps prevent excessive insulin secretion and fat accumulation, creating a metabolic environment in which it is harder to gain weight.

It also promotes a metabolic state in which sugar and fat can be used efficiently. In other words, rather than storing the energy you take in, your body converts it into forms that are easier to use for necessary activity and in your muscles.

Finally, it stimulates insulin secretion and increases glucose use in muscle. This not only improves blood sugar control but also helps maintain and increase muscle mass, a feature that allows weight loss without lowering basal metabolism.

In this way, Mounjaro is thought to produce a stronger weight-loss effect than earlier drugs through its combined actions: “suppressing appetite,” “prolonging fullness,” “stabilizing blood sugar” and “regulating metabolism.”

Woman, abdomen

Mounjaro for weight loss: effects and side effects | A detailed guide to the latest weight-loss treatment

“Lose weight just by taking an injection” — this is the catchphra...

4. How it is given and the treatment schedule

Mounjaro is a once-weekly self-injection that starts at a low dose of 2.5 mg and is increased step by step every few weeks. Mounjaro treatment is simple, using a once-weekly self-injection. Because it uses an injection pen, once you are used to it you can do it yourself at home.

How dosing proceeds

  • Starting dose: 2.5 mg/week
  • Dose escalation steps: every few weeks
    → increased step by step to 5 mg → 7.5 mg → 10 mg …
  • Why: to help your body adjust gradually while keeping side effects down

Length of treatment

  • Continuing for at least 3–6 months is recommended
  • Effects appear gradually, so it is important to keep going without rushing

Things that work well alongside it

  • Adjusting your diet (e.g., dietary guidance from a dietitian)
  • Light exercise (to lose fat while maintaining muscle)
  • Regular health checks by a doctor

In other words, Mounjaro is a “simple once-weekly treatment,” but it works best when combined with a review of your lifestyle habits.

Not sure if it suits you? Start with a consultation.

A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.

No consultation fee (first & follow-up visits)Online consultation available

5. Side effects, risks and how to manage them

Mounjaro commonly causes gastrointestinal symptoms such as nausea and diarrhea, but most can be controlled by starting at a low dose and making adjustments in daily life. While Mounjaro is highly effective, it is not free of side effects. However, most are temporary or mild and can be controlled with some care.

Common side effects (most frequent early in treatment)

  • Gastrointestinal symptoms such as nausea, diarrhea and constipation
  • Nutritional deficiency due to loss of appetite
  • Redness or swelling at the injection site

Rare risks

  • Acute pancreatitis
  • Medullary thyroid carcinoma (reported in animal studies)
  • Hypoglycemia (when used with other diabetes drugs)

Ways to reduce side effects

  • Start at a low dose at first to let your body adjust
  • Avoid fatty meals and binge eating and drinking
  • Drink fluids frequently

In other words, many side effects can be prevented with some care. Avoid using it on your own judgment; it is important to proceed safely under a doctor’s supervision.

6. Differences in approval status between Japan and other countries

Mounjaro is also approved as an anti-obesity drug in the US and EU, but in Japan it is approved only as a diabetes treatment, and use for weight loss is self-pay treatment. There are major differences in how Mounjaro is used overseas and in Japan.

  • US and EU
    It is already approved not only for “diabetes treatment” but also as an “anti-obesity drug.” In the US and Europe, obesity is regarded as “a disease,” and it is common to actively use medication in addition to diet and exercise. As a result, many people are able to receive treatment using their insurance.
  • Japan
    It is currently approved only as a “diabetes treatment,” so when it is used for obesity it is not covered by health insurance and is self-pay treatment. In Japan, the prevailing view is that “obesity should first be addressed by improving lifestyle habits,” so treatment with medication is still limited.

In short, the difference is that overseas, drug treatment is standard, while in Japan, improving lifestyle habits is the basis. As more overseas data accumulate, approval may expand in Japan in the future, but at present its use is limited to self-pay treatment.

7. Precautions when considering starting treatment

When considering Mounjaro, the prerequisite for success is to avoid obtaining it on your own and to always proceed with treatment under a doctor’s supervision. Mounjaro has a strong effect, but without proper management it also carries risks. When considering starting treatment, note the following points.

  • Obtaining or using it on your own judgment is dangerous (avoid online purchases and personal importation)
  • Always have your dose and side effects checked under a doctor’s supervision
  • Maximize results by working with dietitians and exercise instructors

In other words, the key to success is working together with a medical team rather than “relying on the drug alone.”

Summary

Mounjaro has a strong weight-loss effect, but it is essential to understand side-effect management and the fact that it is self-pay treatment. Mounjaro has been shown to have a stronger weight-loss effect than earlier GLP-1 drugs and is an anti-obesity drug attracting worldwide attention. Because it also excels at blood sugar control and improving metabolism, not just weight loss, it greatly expands the options for medical weight loss. Clinical trials have confirmed substantial weight loss and improvements in lifestyle-disease risk, and it can be described as an innovative presence in the field of obesity treatment.

On the other hand, there are limitations regarding side effects, cost and approval status in Japan, so using it casually as a “diet pill” is dangerous. Avoid using it on your own judgment; it is important to always receive appropriate supervision and support from a doctor at a trustworthy medical facility. Combining it with nutritional guidance and exercise therapy can also be expected to produce healthier, more sustainable results.

Ideally, rather than aiming only to “lose weight easily,” it should be positioned as a tool for maintaining health over the long term and improving quality of life. Mounjaro is one strong option for that purpose and may come to play a central role in medical weight loss going forward.

About self-pay treatment and off-label use

Self-pay treatment
Medical weight loss is self-pay treatment (paid in full by the patient) and is not covered by public health insurance.
Off-label use
Using medicines for weight management or weight loss may be off-label use, outside the indications approved in Japan.
Relief System for Adverse Drug Reactions
With off-label use, health damage such as a serious side effect may not be covered by Japan’s Relief System for Adverse Drug Reactions.
Individual differences and the doctor’s judgment
Effects and side effects vary from person to person. A doctor decides after a consultation whether you can use a medicine and which medicine and dose are appropriate. Please tell us in advance about any symptoms, chronic conditions or medicines you are taking.

Frequently asked questions (FAQ)

We have compiled questions patients often ask about medical weight loss with Mounjaro injections. Suitability depends on each person’s constitution and medical history, so please consult a doctor at your consultation for a final decision.

QCan anyone receive Mounjaro injections?
A

In principle, use should be avoided or carefully considered for people who are pregnant or breastfeeding, have a severe gastrointestinal disease, or have had pancreatitis in the past. At our clinic, we carry out a consultation and blood tests beforehand, and a doctor determines whether treatment is suitable before proceeding.

QWhat is the difference between Mounjaro and Ozempic or Rybelsus?
A

Ozempic and Rybelsus act only on the GLP-1 receptor, whereas Mounjaro is a dual receptor agonist that acts on the GIP receptor in addition to GLP-1. Clinical trials have reported greater weight loss than with GLP-1-only drugs, but how well it works varies from person to person, and the drug that suits you depends on your constitution.

QDo the injections hurt? Can I inject myself?
A

The self-injection pen is designed with a thin needle, and many people find it causes little pain. Once you have been shown the technique by a doctor or nurse, you can inject yourself at home once a week. Rotate injection sites and avoid injecting in the same place repeatedly.

QHow long does it take to notice an effect?
A

Results vary, but many people begin to notice changes in appetite within a few weeks to about a month, and steady weight loss is generally noticed after continuing for 3–6 months. Rather than aiming for rapid weight loss in a short time, it is important to work on it over the long term alongside improving your lifestyle habits.

QIs Mounjaro covered by health insurance?
A

When used to treat type 2 diabetes, it may be covered by health insurance, but use for obesity or weight loss is self-pay treatment (not covered by health insurance), and you pay the full cost. You can check the latest prices on our clinic’s official pricing page.

QWill I regain weight if I stop treatment?
A

When the medication is stopped, the appetite-suppressing effect gradually wears off, so weight is thought to return more easily if lifestyle improvements have not been made alongside treatment. At our clinic, we provide follow-up support, including nutritional guidance, to help you maintain your weight after treatment ends.

Who to contact if you have side effects | When to see a doctor

If you have any of the following symptoms, contact us rather than waiting to see what happens. GIP/GLP-1 receptor agonists, including Mounjaro, are known to cause side effects, mainly gastrointestinal symptoms. Most are mild, but serious ones occur in rare cases.

SymptomsPossible causeWhat to do
Ongoing nausea and vomitingGastrointestinal symptoms. The most common side effectContact us if you continue to be unable to keep fluids down
Severe abdominal pain (pain that goes through to the back)Possible acute pancreatitisStop the medication immediately and see a doctor
Cold sweats, palpitations, intense hunger, feeling confused or dazedHypoglycemiaTake sugar immediately and contact us
Skin rash, difficulty breathing, swelling of the face or throatAllergic reactionSeek medical care immediately

Contact: 0120-241-929 (9:00–18:00)
If your symptoms are severe outside these hours, go to your nearest emergency medical facility.

Each clinic’s direct phone number is listed on the clinic information page.

References

The information on medicines in this article is based on the following official materials. For details on dosage, administration and side effects, always check the latest electronic package insert.
Pharmaceuticals and Medical Devices Agency (PMDA), “Mounjaro Subcutaneous Injection Ateos: Electronic Package Insert”
PMDA, “Drug Guide for Patients: Mounjaro Subcutaneous Injection Ateos” (PDF)
Ministry of Health, Labour and Welfare (Japan), “Prevention of Lifestyle-Related Diseases”

When Mounjaro is used for purposes other than obesity disease, it is self-pay treatment and is not covered by public health insurance. Effects and side effects vary from person to person.

Reviewing doctor: Hiroko Oka
Reviewing doctor

Hiroko OkaDirector, Hiro Clinic Kawaguchi (physician)

Japanese Society of Internal Medicine Chair, Fukubikai Medical Corporation / Certified Member, Japanese Society of Internal Medicine Graduated from Toho University School of Medicine and joined the Department of Internal Medicine at Keio University School of Medicine. After training in internal medicine at university and general hospitals, she has worked in obesity treatment and weight-management guidance from an internal-medicine perspective. About our medical review and editorial policy

You may also like

Back to all articles

Ask our AI chat AI chat